A single-cell platform reveals that many genetic mutations converge on shared cellular programs, pointing to simpler, more ...
In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with ...
Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...
Researchers in the lab of Hans-Peter Kiem, MD, PhD, at Fred Hutch Cancer Center have devised a method that could one day treat genetic hematologic disorders by correcting how the body makes blood ...
Three Philadelphia scientists won the 2026 Breakthrough Prize for developing Luxturna, the first FDA-approved gene therapy for a genetic disease, amid new data showing UK cancer cases at record highs.
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results